Users of the Seven Bridges Platform on Amazon Web Services (AWS) can benefit from a range of features and products offered by the world’s largest public cloud. As the established leader in public cloud computing, AWS offers a global distribution of regions and data centers.

Researchers who choose to use the Platform on AWS have the option of storing and analyzing data in various national jurisdictions according to their need. In addition, investigators who already store genomic and other data on Amazon S3 can avoid costly and time-consuming data transfer by running the Seven Bridges Platform on AWS.

Users will also benefit from our 5 years of experience optimizing complex bioinformatics pipelines for specific AWS instances. As ever, all computation cost is passed directly to the user, at no markup.

AWS is also committed to hosting biomedical data assets for the community, including the 1,000 Genomes Project dataset and The Cancer Genome Atlas, access to which Seven Bridges authenticates in our role as NIH Trusted Partner as part of the NCI Cancer Genomics Cloud pilot program.


Users of the Seven Bridges Platform are never locked to any particular infrastructure, be it cloud, local, or hybrid. Our extensive support and development of the Common Workflow Language means that the pipelines you create can be easily moved between your local infrastructure and the cloud, facilitating collaboration, discovery and reproducibility. For example, you can build a workflow on your laptop and then immediately run it in the Seven Bridges Platform on AWS. Users of the Seven Bridges Platform can immediately take their work to the most appropriate computational environment for the task at hand.